Securities & Investment Fraud

Envision Healthcare Corporation Securities Class Litigation

Introduction

Securities fraud class action litigation has been filed on behalf of investors in the securities of Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC). If you purchased or otherwise acquired the securities of Envision between March 2, 2015 and July 21, 2017, inclusive (the “Class Period”), you may move the court for appointment as lead plaintiff by no later than October 3, 2017.

You may retain Lieff Cabraser Heimann & Bernstein, LLP, or other attorneys, as your counsel in the actions. Recognized by the National Law Journal as one of the nation’s top plaintiffs’ law firms, Lieff Cabraser is committed to safeguarding the rights of investors and upholding the integrity of the market. We have significant experience and a successful track record of representing institutional and individual investors in securities and financial fraud litigation.

Envision investors may choose to have Lieff Cabraser review their claim by completing the contact form below. You can also call Sharon M. Lee of Lieff Cabraser at 1-800-541-7358 to discuss the litigation.

Background on the Envision Securities Class Litigation

Envision, based in Nashville, Tennessee, through its subsidiary EmCare Holdings, Inc. (“EmCare”), is one of the largest physician staffing companies for hospital emergency rooms in the United States.

The action alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) EmCare routinely engaged in “surprise billing,” whereby EmCare arranged for patients seeking treatment at in-network facilities to be treated by out-of-network physicians, and subsequently charged significantly higher billing rates; (ii) for this reason, the Company’s statements during the Class Period attributing EmCare’s growth to other factors were false and/or misleading; and (iii) Envision’s revenues from EmCare were not be sustainable.

On July 24, 2017, The New York Times reported that a study conducted by researchers at Yale University found that hospital emergency rooms run by EmCare were much more likely to engage in surprise billing. According to the Times, out of a sample of 194 hospitals emergency rooms run by EmCare, for example, the study found an average out-of-network billing rate of 62%, far higher than the national average. On this news, the price of Envision common stock fell $2.33 per share, or 3.72%, to close at $60.28 per share on July 24, 2017, on elevated trading volume.

Shareholder Contact Form


First Name (required)

Last Name (required)

Email address (required)

Street Address

City

State

Zip

Telephone Day

Telephone Eve

How did you find our site?

Are you currently represented by an attorney?

II. TRANSACTIONS IN ENVISION SECURITIES

Number of shares of Envision securities held immediately before the start of the Class Period on March 2, 2015:

From March 2, 2015 through July 21, 2017, inclusive, I made the following transactions in Envision securities:

PURCHASES

Date
No. of Shares
Price

show more rows

SALES

Date
No. of Shares
Price

show more rows

During the 90 days after July 21, 2017, I made the following transactions in Envision securities:

SALES

Date
No. of Shares
Price

show more rows

Comments & questions:

Please sign me up for your Consumer Law newsletter. Yes
Please leave this field empty.


About Lieff Cabraser

Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York, Nashville, and Seattle, is a nationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility.

The National Law Journal has recognized Lieff Cabraser as one of the nation’s top plaintiffs’ law firms for fourteen years. In compiling the list, the National Law Journal examines recent verdicts and settlements and looked for firms “representing the best qualities of the plaintiffs’ bar and that demonstrated unusual dedication and creativity.” Law360 has selected Lieff Cabraser as one of the Top 50 law firms nationwide for litigation, highlighting our firm’s “laser focus” and noting that our firm routinely finds itself “facing off against some of the largest and strongest defense law firms in the world.” In late 2016, Benchmark Litigation named Lieff Cabraser one of the “Top 10 Plaintiffs’ Firms in America.”